Department of Neurology, Taichung Veterans General Hospital, Taichung, Taiwan.
Department of Medical Education and Research, Taichung Veterans General Hospital, Taichung, Taiwan.
Sci Rep. 2020 Sep 23;10(1):15476. doi: 10.1038/s41598-020-72381-0.
A possible association between depression and either the severity of constipation or dysosmia in Parkinson's disease (PD) patients was investigated in this cross-sectional study. One-hundred six patients who had the history of PD for less than 5 years were recruited. Depression was measured using the Beck Depression Inventory-II (BDI-II), and our patients were divided into depressive and non-depressive groups (DP: BDI-II ≥ 14; n = 22 and NDP: BDI-II < 14; n = 84). Olfactory dysfunction was assessed by the University of Pennsylvania Smell Identification Test (UPSIT). Constipation severity was defined by stool softener dosage and amount. Statistical analyses with one-tailed T- or chi-squared test, odds ratios (OR), and beta-coefficient were used to determine significant differences. Total scores based on the Unified Parkinson's Disease Rating Scale (UPDRS) were significantly higher in the DP group. A significant relationship was observed between PD patients with depression and severe constipation; PD patients with depression were more likely to present with severe constipation (OR 5.81; 95% CI 1.24-27.29, p = 0.026, adjusted for age and gender); but the significance became marginal after adjusted for age, gender and UPDRS part 3 (OR 4.46, 95% CI 0.93-21.33; p = 0.061). However, no association between olfactory dysfunction and depression was detected. There were significant positive correlations between BDI-II scores and severe constipation (β ± SE 7.65 ± 2.02; p = < 0.001, adjusted for age and gender; β ± SE 7.06 ± 2.04; p = 0.001, adjusted for age, gender, and UPDRS-3). Besides, we detected a marginally significant correlation that PD patients with higher BDI-II scores tended to present more severe motor symptoms. Olfactory dysfunction seemed to be less relevant to BDI-II scores. Based on our findings, we speculate that depression may be more closely related to brainstem nuclei than to the limbic pathway.
本横断面研究旨在探讨抑郁症与帕金森病(PD)患者便秘严重程度或嗅觉障碍之间是否存在关联。共招募了 106 名 PD 病史不足 5 年的患者。使用贝克抑郁量表第二版(BDI-II)评估抑郁程度,将患者分为抑郁组(BDI-II≥14;n=22)和非抑郁组(BDI-II<14;n=84)。嗅觉功能障碍采用宾夕法尼亚大学嗅觉识别测试(UPSIT)进行评估。便秘严重程度通过使用大便软化剂的剂量和用量来定义。采用单尾 T 检验或卡方检验、优势比(OR)和β系数进行统计学分析,以确定显著差异。DP 组的统一帕金森病评定量表(UPDRS)总分显著更高。PD 伴抑郁患者与严重便秘之间存在显著相关性;PD 伴抑郁患者更易出现严重便秘(OR 5.81;95%CI 1.24-27.29,p=0.026,校正年龄和性别后);但校正年龄、性别和 UPDRS 第 3 部分后,其显著性变得边缘(OR 4.46,95%CI 0.93-21.33;p=0.061)。然而,未发现嗅觉障碍与抑郁之间存在关联。BDI-II 评分与严重便秘之间存在显著正相关(β±SE 7.65±2.02;p= <0.001,校正年龄和性别;β±SE 7.06±2.04;p=0.001,校正年龄、性别和 UPDRS-3)。此外,我们还发现了一个边缘显著的相关性,即 BDI-II 评分较高的 PD 患者更倾向于表现出更严重的运动症状。嗅觉功能障碍似乎与 BDI-II 评分相关性较低。基于我们的发现,我们推测抑郁可能与脑干部位的核团关系更为密切,而非与边缘通路相关。